Alkaline ceramidase 2 and its bioactive product sphingosine are novel regulators of the DNA damage response

// Ruijuan Xu 1, 2 , Kai Wang 1, 2 , Izolda Mileva 3 , Yusuf A. Hannun 1, 2 , Lina M. Obeid 1, 2, 4 , Cungui Mao 1, 2 1 Department of Medicine, State University of New York at Stony Brook, Stony Brook, NY 11794, USA 2 Stony Brook Cancer Center, State University of New York at Stony Brook, Stony Brook, NY 11794, USA 3 Lipidomics Core Facility, State University of New York at Stony Brook, Stony Brook, NY 11794, USA 4 Ralph H. Johnson Veterans Administration Hospital, Stony Brook, NY 11794, USA Correspondence to: Cungui Mao, e-mail: cungui.mao@stonybrook.edu Keywords: ceramide, Golgi, p53, programmed cell death, reactive oxygen species Received: September 18, 2015      Accepted: January 29, 2016      Published: March 01, 2016 ABSTRACT Human cells respond to DNA damage by elevating sphingosine, a bioactive sphingolipid that induces programmed cell death (PCD) in response to various forms of stress, but its regulation and role in the DNA damage response remain obscure. Herein we demonstrate that DNA damage increases sphingosine levels in tumor cells by upregulating alkaline ceramidase 2 (ACER2) and that the upregulation of the ACER2/sphingosine pathway induces PCD in response to DNA damage by increasing the production of reactive oxygen species (ROS). Treatment with the DNA damaging agent doxorubicin increased both ACER2 expression and sphingosine levels in HCT116 cells in a dose-dependent manner. ACER2 overexpression increased sphingosine in HeLa cells whereas knocking down ACER2 inhibited the doxorubicin-induced increase in sphingosine in HCT116 cells, suggesting that DNA damage elevates sphingosine by upregulating ACER2. Knocking down ACER2 inhibited an increase in the apoptotic and necrotic cell population and the cleavage of poly ADP ribose polymerase (PARP) in HCT116 cells in response to doxorubicin as well as doxorubicin-induced release of lactate dehydrogenase (LDH) from these cells. Similar to treatment with doxorubicin, ACER2 overexpression induced an increase in the apoptotic and necrotic cell population and PARP cleavage in HeLa cells and LDH release from cells, suggesting that ACER2 upregulation mediates PCD in response to DNA damage through sphingosine. Mechanistic studies demonstrated that the upregulation of the ACER2/sphingosine pathway induces PCD by increasing ROS levels. Taken together, these results suggest that the ACER2/sphingosine pathway mediates PCD in response to DNA damage through ROS production.